6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid
C23H13F6NO5S — CID 155521917
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid
6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid (PubChem CID 155521917) has the molecular formula C23H13F6NO5S and a molecular weight of 529.41 g/mol. Its IUPAC name is 6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid.
Molecular Properties
| Compound Name | 6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid |
|---|---|
| PubChem CID | 155521917 |
| Molecular Formula | C23H13F6NO5S |
| Molecular Weight | 529.41 g/mol |
| Exact Mass | 529.04 |
| IUPAC Name | 6-[3-(difluoromethoxy)-5-fluorophenyl]-1-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxylic acid |
| SMILES | O=C(O)c1cc2ccc(-c3cc(F)cc(OC(F)F)c3)cc2n1S(=O)(=O)c1cccc(C(F)(F)F)c1 |
| InChI | InChI=1S/C23H13F6NO5S/c24-16-6-14(7-17(11-16)35-22(25)26)12-4-5-13-9-20(21(31)32)30(19(13)8-12)36(33,34)18-3-1-2-15(10-18)23(27,28)29/h1-11,22H,(H,31,32) |
| InChIKey | NUNKTCTZZRZGKJ-UHFFFAOYSA-N |
| XLogP | 6.00 |
| TPSA | 85.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 529.41 |
| LogP ≤ 5 | 6.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155521917 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.